ENDOSCOPIC GORE SEAMGUARD BIOABSORBABLE STAPLE LINE REINFORCEMENT
Report
- Report Number
- 3003910212-2020-00114
- Event Type
- Injury
- Date Received
- July 8, 2020
- Date of Event
- April 16, 2018
- Report Date
- June 12, 2020
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- FTM
- PMA / PMN Number
- K043056
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- PHYSICIAN
Narratives
PATIENT INFORMATION WAS REQUESTED BUT NO INFORMATION WAS PROVIDED. ADDITIONAL INFORMATION SUCH AS DATE OF EVENTS, LOT/SERIAL NUMBERS WERE REQUESTED, BUT NO INFORMATION HAS BEEN PROVIDED.
THE FOLLOWING PUBLICATION WHICH MENTIONS GORE® SEAMGUARD® BIOABSORBABLE STAPLE LINE REINFORCEMENT WAS REVIEWED: RETROSPECTIVE COMPARISON OF SINGLE-PORT SLEEVE GASTRECTOMY VERSUS THREE-PORT LAPAROSCOPIC SLEEVE GASTRECTOMY: A PROPENSITY SCORE ADJUSTMENT ANALYSIS. PURPOSE: EVALUATE THE EFFICACY OF SINGLE-PORT SLEEVE GASTRECTOMY (SPSG) AND THEN COMPARE IT TO A LESS-INVASIVE SLEEVE APPROACH (THREE-PORT) (3PSG) ACCORDING TO A PROPENSITY SCORE (PS) MATCHING ANALYSIS. MATERIALS AND METHODS: WE ANALYZED ALL PATIENTS WHO UNDERWENT SG THROUGH A THREE-PORT OR A SINGLE-PORT LAPAROSCOPIC APPROACH. RESULTS: AFTER 2 YEARS, THE FOLLOW-UP WAS COMPLETED IN 84% PATIENTS TREATED WITH 3PSG AND 95% PATIENTS OF THE SPSG GROUP. EXCESS WEIGHT LOSS (EWL) WAS COMPARABLE FOR THE FIRST YEAR OF FOLLOW-UP WITHIN THE TWO GROUPS EXCEPT FOR THE CONTROLS AT 3 MONTHS IN WHICH THE SPSG GROUP SHOWED A HIGHER EWL. CONCLUSION: WE DEMONSTRATED THE EFFICACY OF SPSG IN BARIATRIC SURGERY EVEN COMPARED TO ANOTHER, LESS INVASIVE, LAPAROSCOPIC SG APPROACH (THREE-PORT). THE ARTICLE REPORTS, "LAPAROSCOPY REVISION FOR BLEEDING ON THE CUTTING LINE WAS REQUIRED IN TWO PATIENTS OF THE 3PSG GROUP AND ONE PATIENT OF THE SPSG GROUP."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 708272 | ENDOSCOPIC GORE SEAMGUARD BIOABSORBABLE STAPLE LINE REINFORCEMENT | MESH, SURGICAL | FTM | W.L. GORE & ASSOCIATES |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |